A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers
Multilevel Intervention to Improve Follow-up Colonoscopy Rates After Abnormal FIT Results in Large FQHC
3 other identifiers
interventional
1,500
1 country
2
Brief Summary
This clinical trial evaluates a clinic-wide intervention called Primary Care-Gastrointestinal (GI) Connect for improving follow-up colonoscopy rates in patients at a Federally Qualified Health Center (FQHC) who have an abnormal fecal immunochemical test (FIT) result. Colorectal cancer screening reduces colorectal cancer incidence and mortality but is underutilized.The most accessible, feasible, and common colorectal cancer screening modality for average-risk individuals in low resource settings such as FQHCs is the stool-based FIT. However, the benefit of FIT screening on colorectal cancer risk is realized only if individuals with abnormal FIT results undergo timely follow-up colonoscopy. Follow-up colonoscopy rates are low and there are many barriers to follow-up colonoscopy in safety net settings such as FQHCs. Effective interventions that are multi-component and improve care coordination are needed to improve abnormal FIT follow-up rates in FQHCs. The Primary Care-GI Connect intervention includes components that enhance care coordination, standardize the referral process, and engage both primary care and specialist physicians. This clinic-wide intervention may improve rates of follow-up colonoscopy after abnormal FIT results in patients seen at FQHCs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2025
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 29, 2024
CompletedFirst Posted
Study publicly available on registry
August 23, 2024
CompletedStudy Start
First participant enrolled
April 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 31, 2029
February 9, 2026
February 1, 2026
3.9 years
July 29, 2024
February 5, 2026
Conditions
Outcome Measures
Primary Outcomes (14)
Follow-up colonoscopy rates
Evaluated in patients with an abnormal fecal immunochemical test (FIT) result using electronic health record data. Will use a difference-in-differences approach, assessing whether change in completion rates from baseline to the implementation period differs between the intervention and usual care conditions, thus accounting for potential differences among clinics pre-implementation. Will fit a mixed effects logistic regression model with a dependent variable of patient-level colonoscopy completion within 6 months (yes/no).
At 6 months
Implementation quality: fit tracker
The Investigators will measure the percent of cases for which the FIT tracker is used, as well as its use for each step in the process. For these measures, we will also measure time to completion.
Monthly intervals up to 3 years
Implementation quality: patient notification
The Investigators will measure both the percent of patients who are notified of their abnormal results as well as the time to notification.
Monthly intervals up to 3 years
Implementation quality: patient referral
The Investigators will measure the percent of patients who receive a referral.
Monthly intervals up to 3 years
Implementation quality: Time to patient referral
The Investigators will measure the time to patient referral.
Monthly intervals up to 3 years
Implementation quality: use of referral template as percent completion of interventions
The Investigators will measure the percent completion of interventions for patients at each step.
Monthly intervals up to 3 years
Implementation quality: referral template in time to completion
The Investigators will measure the time to completion of interventions.
Monthly intervals up to 3 years
Implementation quality: patient education
The Investigators will measure the percent of cases in which patient education is delivered.
Monthly intervals up to 3 years
Implementation quality: patient education
The Investigators will measure the time to delivery of patient education when it is offered.
Monthly intervals up to 3 years
Implementation quality: Patient attendance: completion of a pre-colonoscopy visit
The Investigators will measure the percent of patients who complete a pre-colonoscopy visit.
Monthly intervals up to 3 years
Implementation quality: time to completion of a pre-colonoscopy visit
The Investigators will measure the time to completion of a pre-colonoscopy visit.
Monthly intervals up to 3 years
Implementation quality: receipt of colonoscopy and pathology results at Northeast Valley Health Corporation
The Investigators will measure the percent of patients for which colonoscopy and pathology results are received at NEVHC.
Monthly intervals up to 3 years
Implementation quality: receipt of colonoscopy and pathology results at Northeast Valley Health Corporation over time
The Investigators will measure the time to retrieval of colonoscopy and pathology results received at NEVHC.
Monthly intervals up to 3 years
Cost-effectiveness
Will use standard cost-effectiveness techniques (including time discounting) to conduct an incremental cost-effectiveness analysis, measuring the Incremental Cost-Effectiveness Ratio of the usual care and Primary-care GI connect intervention conditions.
Up to 3 years
Secondary Outcomes (6)
Time to colonoscopy
0-24 months
Follow-up colonoscopy rates
At 9 months and at 12 months
Factors associated with Implementation
At pre-intervention (1-2 years) and at the implementation midpoint (3-4 years)
Reported challenges to implementation
Up to 3 years
Intervention adaptations
Up to 3 years
- +1 more secondary outcomes
Study Arms (2)
Arm I (usual care)
ACTIVE COMPARATORPatients receive clinical care consistent with current practice at NEVHC. Patients have their EHRs reviewed monthly by the Primary Care FIT Tracker for abnormal FIT results and patients with abnormal FIT results receive standardized communication from FIT QI champions about their results and receive a referral to gastroenterology.
Arm II (Usual care + Primary Care - GI Connect)
EXPERIMENTALPatients receive clinical care consistent with current practice at NEVHC as described in Arm I. Patients also receive enhanced GI care coordination from GI liaisons, who generate GI FIT Tracker reports and use the GI FIT Tracker reports to follow patients with abnormal FIT results. Patients receive navigation services including contact from GI liaisons about making a GI appointment and enhanced communication between GI specialists and the NEVHC. Patients receive referral to gastroenterology following a standardized referral template and receive colonoscopy education including an informational sheet at the time of referral and a 20-minute pre-colonoscopy educational video. Patients receive a text message at the time of colonoscopy referral emphasizing the importance of colonoscopy after abnormal FIT result.
Interventions
Undergo FIT result review by Primary Care FIT Tracker
Undergo generation and review of GI FIT Tracker report
Receive navigation from GI liaisons
Receive follow-up text message
Receive clinical care consistent with current practice
Receive standardized communication from FIT QI champion
Receive enhanced GI care coordination
Watch pre-colonoscopy educational video
Eligibility Criteria
You may qualify if:
- adult care NEVHC clinic sites
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of California at Los Angeles
Los Angeles, California, 90095-1406, United States
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, 90095, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Folasade P May, MD, PhD
UCLA / Jonsson Comprehensive Cancer Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 29, 2024
First Posted
August 23, 2024
Study Start
April 22, 2025
Primary Completion (Estimated)
February 28, 2029
Study Completion (Estimated)
August 31, 2029
Last Updated
February 9, 2026
Record last verified: 2026-02